CoLucid Pharmaceuticals' (CLCD) Price Target Raised to $52 at Ladenburg Thalmann
Tweet
Share
E-mailGet Alerts CLCD Hot Sheet
Price: $46.53 --0%
Rating Summary:
3 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
3 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Ladenburg Thalmann maintained a Buy rating on CoLucid Pharmaceuticals (NASDAQ: CLCD) and raised its price target to $52.00 (from $23.00)
For an analyst ratings summary and ratings history on CoLucid Pharmaceuticals click here. For more ratings news on CoLucid Pharmaceuticals click here.
Shares of CoLucid Pharmaceuticals closed at $10.66 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acrivon Therapeutics Inc (ACRV) PT Lowered to $22 at Jones Trading
- TechnipFMC (FTI) PT Raised to $30 at BTIG
- Tyler Tech (TYL) PT Raised to $500 at Oppenheimer
Create E-mail Alert Related Categories
Analyst PT Change, Trader TalkRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
